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ABSTRACT: Metabolomics has become an important tool to
study host-pathogen interactions and to discover potential
novel therapeutic targets. In an attempt to develop a better
understanding of the process of pathogenesis and the
associated host response we have used a quantitative 1H
NMR approach to study the metabolic response to diﬀerent
bacterial infections. Here we describe that metabolic changes
found in serum of mice that were infected with Staphylococcus
aureus, Streptococcus pneumoniae, Escherichia coli and Pseudo-
monas aeruginosa can distinguish between infections caused by
Gram-positive and Gram-negative bacterial strains. By
combining the results of the mouse study with those of
bacterial footprinting culture experiments, bacterially secreted metabolites could be identiﬁed as potential bacterium-speciﬁc
biomarkers for P. aeruginosa infections but not for the other strains. Multivariate statistical analysis revealed correlations between
metabolic, cytokine and physiological responses. In TLR4 and TLR2 knockout mice, host-response pathway correlated
metabolites could be identiﬁed and allowed us for the ﬁrst time to distinguish between bacterial- and host-induced metabolic
changes. Since Gram-positive and Gram-negative bacteria activate diﬀerent receptor pathways in the host, our results suggest that
it may become possible in the future to use a metabolomics approach to improve on current clinical microbiology diagnostic
methods.
KEYWORDS: metabolomics, 1H NMR spectroscopy, Gram-negative and Gram-positive bacterial infections,
bacteria-secreted metabolites, knockout mice, host response, metabolic responses, physiological responses, cytokine responses,
multivariate data analysis
■ INTRODUCTION
The emergence of multiple antibiotic-resistant Gram-positive
and Gram-negative bacteria in hospital and community settings
requires novel approaches for rapid diagnosis and treatment.
1−3
The clinical diagnosis of bacterial infections is currently still
mostly based on recovering and culturing of microorganisms
from patients’ blood or other bodily ﬂuids. Molecular tests to
detect infectious agents are increasingly being used in many
clinical laboratories; however, they have not yet become part of
routine practice. The nonmolecular diagnostic tests lack
diagnostic accuracy, are time-consuming, labor-intensive and
can give erroneous information, particularly in immunodeﬁcient
patients.
4 Most importantly, the tests are not sensitive, and as
such at least 50% of bacterial infections go undetected by state
of the art clinical methods. These problems have led to an
emerging interest in identifying disease speciﬁc biomarkers or
other physiological indicators that can predict the severity and
the nature of bacterial infections. Moreover, collectively, such
biological indicators can potentially guide the selection of the
optimal antibiotic treatment.
5 For example, recently, procalci-
tonin, a peptide hormone and cytokine that is mainly produced
in response to bacterial infections, was found to be a
convenient diagnostic marker to distinguish between bacterial
and viral infections.
4,6 However, a single biomarker has major
limitations and is often equivocal. Moreover, to date, the
diﬀerentiation between infections caused by diﬀerent bacterial
strains is still challenging yet would certainly aid physician
treatment decisions.
In recent years, the focus for ﬁnding novel diagnostic tools
has moved from single disease-speciﬁc markers to bioproﬁles or
biosignatures comprising a well-deﬁned set of reliable molecular
indicators






allows researchers to characterize and quantify a plethora of low
molecular mass metabolites from bioﬂuids such as urine, serum,
and cerebrospinal ﬂuid. Like the other “omics” technologies,
metabolomics also relies on systematic data analysis using
multivariate pattern recognition techniques.
12−14 NMR metab-
olomics has been shown to produce highly quantitative and
reproducible results.
15 In previous studies aimed at developing
new methods for early diagnosis of bacterial infections, the
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growing bacterial cultures
16 as well as for the diﬀerentiation
between bacterial and viral meningitis.
17 Furthermore, diﬀerent
bacterial lower respiratory tract infections have been inves-
tigated in mouse models and human patients as well.
18,19
Metabolomics oﬀers a unique approach to characterize all the
metabolic changes that occur in an organism in response to
biological and toxicological stimuli.
15,20,21 In the case of
infectious diseases, the metabolic proﬁles of bodily ﬂuids are
expected to reﬂect both the molecules generated by the innate
defense response as well as metabolites that are secreted by the
pathogens. In addition, host cellular events, such as altered
energy metabolism, which are a direct result of the disease, will
occur in parallel.
The pathogenicity of bacteria is usually caused by bacterial
molecular elements such as toxins, exoenzymes, adhesins, as
well as immune-modulating proteins that are released. Many of
these PAMPs are recognized by the Toll-like receptor
transmembrane protein family which plays a key role in
mediating the systemic responses to invading pathogens.
22 In in
vitro studies speciﬁc ligands have been identiﬁed for diﬀerent
TLRs such as Gram-negative bacterial lipopolysaccharide for
TLR4 and lipoteichoic acid from the Gram-positive cell wall for
the TLR2/TLR6 heterodimer.
23,24 While the TLR4-dependent
recognition of LPS is very well-established as the central line of
host defense against invading Gram-negative pathogens, there is
now growing evidence that LTA may in fact activate additional
anti-inﬂammatory properties and pathways.
25,26 Consequently,
rather than using LTA, synthetic peptides such as the TLR1/
TLR2 agonist Pam3Cys and the TLR2/TLR6 agonist MALP2
are used instead to activate these TLRs.
Since Gram-negative and Gram-positive bacteria act on
diﬀerent receptors, we can hypothesize that the host metabolic
response will be distinct in each case. The aim of our study is to
evaluate this notion. Therefore, in this work we have analyzed
serum from mouse models of bacterial infections (Staph-
ylococcus aureus, Streptococcus pneumoniae, Escherichia coli, and
Pseudomonas aeruginosa) and examined low-molecular-weight
pathogen-speciﬁc biomarkers through NMR metabolomics. An
extensive array of physiological and immunological data was
measured to conﬁrm that a systemic infection was established
in all cases. To diﬀerentiate the metabolites according to their
origin, we compared the results of the in vivo studies with those
obtained in bacterial culture experiments. By comparing serum
metabolite changes resulting from LPS or MALP2 treatment of
the mice and from studies of TLR4 and TLR2 knockout mice
we could identify those metabolites generated by the host
response. Finally, we incorporated all the metabolic, physio-
logical, and immunological data into one descriptive model of
disease, which showed good correlations between the various
parameters.
■ MATERIALS AND METHODS
Bacteria and Growth Conditions
Bacterial Strains. Experiments were performed with two
Gram-positive bacterial strains (Streptococcus pneumoniae (SPN
15814 strain) and Staphylococcus aureus (Xen29)) and with two
Gram-negative bacteria (Pseudomonas aeruginosa (PA01) and
Escherichia coli (Xen14)). Both the E. coli and the S. aureus
strain (Caliper Life Sciences, Hopkinton, MA) possess a stable
copy of the Phosphorhabdus luminescens lux operon ABCDE on
the bacterial chromosome which allowed us to monitor the
progression of the infection by bioluminescence.
Cultivation. Prior to analysis, frozen stock suspensions of
bacteria were cultured overnight in 5 mL of Luria-Bertani
medium (S. aureus, P. aeruginosa, E. coli) or brain-heart infusion
broth (S. pneumoniae)a t3 7°C with shaking at 200 rpm. To
guarantee strain selectivity, media contained kanamycin in an
appropriate concentration (200 μg/mL for S. aureus and 30 μg/
mL for E. coli). For the bacterial foot- and ﬁngerprint analysis, 1
mL of the overnight culture was reinoculated into 50 mL of the
corresponding culture broth, and bacteria were cultured in 500
mL ﬂasks under the same conditions up to an OD600 (optical
density at 600 nm) of 0.6. For each bacterial strain, cultures
were prepared in duplicate. For the in vivo experiments in mice,
1 mL of the overnight culture was reinoculated into 5 mL of
medium and incubated for 3−5 h at 37 °C with shaking at 250
rpm.
Cell Concentration. The cell concentration was deter-
mined by measuring the OD600 spectrophotometrically and by
counting the colony-forming units (CFU). A bacterial sample
was serially diluted, and a known volume was plated either onto
LB or BHI agar. The cell concentration was obtained by
counting the number of colonies that had formed.
Intracellular Metabolite Extraction by Cold Methanol
(Fingerprinting)
For each bacterial culture a total amount of 50 mL was
collected in the exponential phase (OD600 = 0.6) on separate
0.22 μm ﬁlters.
27 Immediately after the disappearance of the
culture medium the unwashed ﬁlters were transferred to liquid
nitrogen. Subsequently each ﬁlter was crushed into separate
conical tubes and was suspended in 5 mL of 100% cold
methanol which was cooled to below -40 °C in a dry ice-
ethanol bath. Three freeze-thaw cycles were applied to break
the cell wall and to release the intracellular metabolites. The
lysates were centrifuged at 4000g for 15 min at 4 °C, and the
supernatants were transfer r e di n t oac l e a nt u b e .T h e
metabolites were puriﬁed by adding 5 mL of water and 10
mL of chloroform and shaking for 5 min. The water-methanol
phase contained the metabolites and was separated from the
lipophilic chloroform-phase by centrifugation for 15 min at
4000g. The metabolite solution was transferred to a clean tube,
and 1 mL was aliquoted into 1.5 mL tubes 3×. The samples
were dried in a speed-vacuum evaporator, resuspended in 500
μLo fD 2O, and stored at −20 °C.
Bacterial Culture Growth Medium (Footprinting)
Samples for footprinting were prepared simultaneously with
intracellular metabolite extraction. After bacterial cells were
separated by ﬁltration, the ﬁltrate was stored at -20 °C until the
NMR measurements were performed.
Mice
Experiments were performed on 5 to 8 weeks-old (20-35 g)
male mice. TLR4-/- mice and C57BL/6 mice were purchased
from The Jackson Laboratory (Bar Harbor, ME). TLR2-/- mice
were provided by Prof. Shizuo Akira (Osaka University, Japan).
Mice were maintained in a pathogen-free environment. The
mice had access to food and water ad libitum. All procedures
performed were approved by the University of Calgary Animal
Care Committee and were in accordance with the Canadian
Guidelines for Animal Research.
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Bacterial cultures in the exponential phase (see Bacteria and
Growth Conditions) were centrifuged for 10 min at 3000 rpm
and washed twice with saline, and the cell concentration of the
bacterial suspension was adjusted by spectrophotometry at 600
nm. To induce the diﬀerent bacterial infections in mice, animals
were injected intraperitoneally with 1 mL of the bacterial
suspensions adjusted to the following concentrations: S. aureus:
1 × 107 CFU/mL; S. pneumoniae:1× 107 CFU/mL; P.
aeruginosa:1× 106 CFU/mL; E. coli:1× 107 CFU/mL. For P.
aeruginosa concentrations of 7 × 102 CFU/ml, 8 × 104 CFU/
mL and 5 × 106 CFU/mL were also investigated.
Treatment of Mice with LPS and MALP2
MALP2 and LPS (LPS from Escherichia coli O111:B4) were
purchased from Alexis Biochemicals (Enzo Life Sciences, Inc.,
Plymouth Meeting, PA) and List Biologicals (Burlington,
Ontario, Canada), respectively. MALP2 (5 μg) was dissolved in
200 μL of saline and intraperitoneally injected into wild-type
and TLR2-/- mice. For the corresponding LPS experiment, 200
μL of saline containing 0.5 mg of LPS/kg mouse were
administered in wild-type and TLR4-/- mice. Control mice
received 200 μL of saline ip.
Physiological Parameters
Weight. Prior to administration of bacteria, LPS, MALP2 or
saline and 24 h post administration, body weight (Metler
Toledo, Columbus, OH) was determined and calculated as
weight loss normalized to the primary body weight.
White Blood Cell Count (WBC Count). Twenty-four
hours after treatment and infection, mice were anesthetized by
inhalation with isoﬂurane (Bimeda-MTC, Cambridge, Ontario,
Canada), and 500 μL of blood was collected via cardiac
puncture. Circulating leukocyte counts were determined with a
Bright-line hemocytometer (Hausser Scientiﬁc, Horsham, PA).
Blood smears were stained with Wright-Giemsa (VWR,
Edmonton, Alberta, Canada) and leukocyte diﬀerentials
determined from a count of 100 cells. The remaining blood
volume was allowed to sit at room temperature for 10-30 min
to clot and spun down at 5000 rpm for 10 min, and the top
layer of serum was collected and frozen at -20 °C to be used
later for metabolite and cytokine measurements.
Peritoneal Lavage. After the collection of blood, mice
were sacriﬁced, and a peritoneal lavage was performed using 3
mL of warm saline. The exudate was recovered following a 60 s
gentle manual massage, and leukocytes were counted with a
hemocytometer.
Myeloperoxidase (MPO) Activity. From sacriﬁced mice,
lung tissue was collected and used for an MPO activity assay.
MPO is a myeloid cell-speciﬁc enzyme in neutrophils, and its
activity was measured to determine the neutrophil inﬂux into
the lung.
28,29 Lung tissues were prepared in 96-well plates and
processed using hexadecyltrimethylammonium bromide (for
enzyme extraction) and dianisidine-H2O2 (as the colorimetric
substrate) (Sigma, St. Louis, MO). The assay was performed
following a previously published protocol.
30 The change in
absorbance at 450 nm in the 96-well plates was determined
over 60 s using a kinetic microplate reader (Molecular Devices,
Sunnyvale, CA).
Lung CFU. At 24 h after inoculation mice were sacriﬁced
and lungs were collected and homogenized in 1 mL of sterile
PBS. Bacterial CFU were determined by culturing serial
dilutions on LB agar plates overnight at 37 °C.
Chemokines and Cytokines. The analysis of the cytokines
and chemokines in mouse serum was performed with a BioPlex
8 plex immune assay kit (IL-6, IL-10, G-CSF, KC, MCP-1,
MIP-1a, RANTES, TNFa) from BioRad (Herkules, CA)
according to the manufacturer’s speciﬁcations. The plate was
read on a Luminex 200 apparatus (Applied Cytometry Systems,
UK). The acquisition and analysis were performed with the
STarStation V.2.3 software from Applied Cytometry Systems.
NMR Sample Preparation
All of the serum samples from mice as well as the samples for
footprint and ﬁngerprint-analysis were ﬁltered in 3-kDa-cutoﬀ
spin columns (3 K Nanosep: Omega; VWR, Edmonton,
Alberta, Canada), and ﬁltered protein was rinsed using an
additional 100 μLo fD 2O. Prior to use, ﬁlters were washed 5
times with water and then D2O to remove the glycerol
conservation agent. The ﬁnal sample volume ranged from 300
to 500 μL and was transferred to clean microfuge tubes.
Samples were brought to a total volume of 650 μL by addition
of D2O, 40 μL of sodium azide (1 M NaN3 solution), and 140
μL of phosphate buﬀer (500 mM NaH2PO buﬀer solution at
pH 7.0) containing 2.5 mM of 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS) as an internal chemical shift and concentration
standard, and the pH was adjusted to 7.00 ± 0.05.
12,31,32
NMR Acquisition
All NMR experiments were acquired on a Bruker AVANCE
600 spectrometer equipped with a 5 mm TXI probe (Bruker,
Milton, Ontario, Canada) at 298 K. The 1D 1H NMR spectra
were obtained using a standard Bruker 1D nuclear Overhauser
enhancement spectroscopy (NOESY)-presaturation pulse
sequence (noesypr1d)
13,33 in which the residual water peak
was irradiated during the relaxation delay of 1.0 s and during
the mixing time of 100 ms. For an overall recycle time of 5 s an
acquisition time of 2 s and an initial relaxation delay of 3 s was
used. A total of 2048 and 1024 scans were collected for samples
of mouse serum and culture experiments, respectively. All
spectra were acquired, zero ﬁlled to 64k points and Fourier
transformed. The spectra were manually corrected for phase
and baseline distortions within Topspin (Bruker Biospin, Ltd.)
and were referenced to the DSS resonance at 0.0 ppm.
Additional two-dimensional NMR experiments such as total
correlation spectroscopy (2D 1H-13C TOCSY) and hetero-
nuclear single quantum coherence spectroscopy (2D 1H-13C
HSQC) were performed for chemical shift assignments and
veriﬁcation.
Targeted Metabolite Proﬁling
1D 1H NMR spectra were imported into Chenomx NMR Suite
version 4.6 (Chenomx Inc., Edmonton, Canada) for metabolite
identiﬁcation and quantiﬁcation by targeted metabolite
proﬁling analysis in the Proﬁler module which is linked to a
library representing over 260 metabolite entries.
13 To
determine the concentration of individual compounds the
concentration of DSS was used as reference. Each compound
concentration was then normalized to the sum of all
concentrations, excluding the two highest concentrated
metabolites, glucose and lactate, which otherwise would
dominate the normalization.
34 These normalized data were
then used for multivariate statistical data analysis. A total of 43
metabolites were proﬁled in serum spectra. For the ﬁngerprint
and footprint spectra 39 metabolites were identiﬁed.
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The ﬁnal data set used for the multivariate analysis consisted of
eight wild-type C57BL/6 mice for each bacterial infection (S.
aureus, S. pneumoniae, E. coli, P. aeruginosa), eight wild-type
mice with LPS injection, seven wild-type mice with saline, and
six mice with MALP2 treatment. Four TLR4-/- mice were
injected with either E. coli or LPS, and four TLR2-/- mice were
infected with S. aureus and treated with MALP2, respectively.
For control experiments, four saline-treated knockout mice
were used for each group. For foot- and ﬁngerprint analysis, six
samples per bacterial strain were prepared, respectively, using
two biological duplicates. Chemometric analysis was performed
using SIMCA-P version 11.5 (Umetrics, Umea, Sweden) and
both supervised (partial least-squares, partial least-squares
discriminant analysis, orthogonal partial least-squares discrim-
inant analysis), and unsupervised (principle component
analysis) projection techniques were applied to the diﬀerent
data sets.
PCA models were applied to each treatment-control data set
as well as to all serum samples collected from S. aureus, S,
pneumoniae, E. coli, and P. aeruginosa infected mice. As an
unsupervised method, PCA deﬁnes the major sources of
variance without over interpretation and allows outliers to be
identiﬁed.
14 To reveal diﬀerences in the metabolomic proﬁles
which may be masked by PCA using all data points, supervised
PLS-DA modeling was applied using a binary variable as class-
membership for diﬀerent bacterial infections and treatments.
By OPLS-DA an orthogonal projection was conducted for
each individual bacteria-host and footprint-medium data set.
However these supervised models may also contain variation
that is not class-related and which can be avoided applying PLS
analysis to the 1H NMR spectral information with additional
orthogonal class-characteristics. Here we conducted PLS
analysis using a metabolomic matrix x and an identity-matched
matrix y containing a set of physiological-immunological data in
order to ﬁnd connections between the two sets of data. In our
calculations, we used a total loadings set consisting of eight
physiological (weight, WBC counts, lymphocytes, monocytes,
neutrophiles, eosinophiles, MPO, leukocytes in peritoneal
lavage), eight immunological parameters (IL-6, IL-10, G-CSF,
KC, MCP-1, MIP-1a, RANTES, TNFa), and 43 quantiﬁed
metabolites. The quality of each model was assessed by the
parameters R2 and Q2. R2 is the goodness-of-ﬁt parameter, the
percentage of variation explained in the data, and Q2 the




Validation of the Mouse Model for Diﬀerent Bacterial
Infections
To establish a reliable mouse model, S. aureus infections were
induced with the bioluminescence Xen29 strain in wild-type
C57BL/6 mice by intraperitoneal (ip, 1 × 107 CFUs),
intravenous (iv, 1 × 107 CFUs), and subcutaneous (sc, 1 ×
108 CFUs) administration. Their progression was monitored by
bioluminescence as well as by NMR-based metabolomics. Over
the course of 24 h, the intensity of the bioluminescence
changed signiﬁcantly when following the concentration of
detectable pathogens located closely to the skin surface (Figure
1A). The fast systemic distribution of bacteria after intra-
peritoneal invasion led to a loss in intensity after 24 h compared
to 4 h, while for the subcutaneous injection both an increase in
bacterial density as well as an expanded infected skin area
developed. Because of immediate dispersion in blood after
intravenous administration, much of the bacteria was rapidly
cleared and no bioluminescence signal could be detected in
these mice after 4 or 24 h. After bioluminescence monitoring,
serum was collected by cardiac puncture, and 43 metabolites
were identiﬁed and quantiﬁed by 1H NMR and compared with
those detected in controls (untreated, n = 14; sham infected
with 1 mL of saline ip injected, n = 7) using multivariate
statistical pattern recognition techniques. Principle component
analysis (PCA; three components, R2 = 0.48, Q2 = 0.25) scores
plots revealed complete class distinction in the second
component between infected and healthy subjects (Figure
1B). No separation was observed between untreated animals
and those having received an ip injection of 1 mL saline.
However in the group of the infected subjects, serum samples
of infected mice having the same site of infection grouped
together in the ﬁrst component according to the similarities in
their metabolomic proﬁles. Additionally, CFU counts in lung
tissue conﬁrmed reliable systemic progression of the infection
for both the intraperitoneal and intravenous routes of
administration. Since ip invasion of bacteria is one of the
Figure 1. Comparison of intravenous (iv), intraperitoneal (ip), and
subcutaneous (sc) administration of S. aureus. (A) S. aureus Xen29
possessing a stable copy of the luxABCDE operon was imaged to study
the redistribution of bacteria after ip and sc injection. Images obtained
after 4 and 24 h are shown. While there appears to be little
redistribution from the initial injection site after sc injection, good
redistribution is observed following ip injection. (B) PCA analysis
(three components, R2 = 0.48, Q2 = 0.25) of serum of S. aureus
infected mice and controls. The analysis shows that the three routes of
administration (sc, ip, iv) give comparable results when compared
against control mice and mice injected with saline. In particular, ip and
sc administration show good agreement with each other. Nontreated
mice and saline injected mice behaved in a very similar manner.
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threatening septicemic conditions in patients, the ip infection
model was utilized for all further investigations.
In our study, we investigated host-microbe interactions using
two Gram-positive and two Gram-negative organisms: S. aureus,
S. pneumonia, E. coli, and P. aeruginosa. The bacterial dose was
adjusted to 107 CFU/mL for S. aureus, S. pneumoniae, and E.
coli and 106 CFU/mL for P. aeruginosa and resulted in a survival
rate of 100% on day one post injection. Twenty-four hours post
bacteria administration, mice (n = 8 for each kind of infection)
showed CFUs in the lungs (results not shown) as a result of a
systemic progression of the bacterial infection. Additionally,
mice were examined according to their health condition and
status of inﬂammation by comparing body weight, Myeloper-
oxidase (MPO) activity in the lungs, white blood cell counts in
blood and peritoneal lavage, as well as cytokine/chemokine
levels (IL-6, IL-10, G-CSF, KC, MCP-1, MIP-1a, RANTES,
TNFa) in serum (Figure 2). The data were compared with
sham mice (ip injection of 1 mL of saline, n = 7) and animals
having obtained an intraperitoneal injection of LPS (n = 8) and
MALP2 (n = 6). For LPS and MALP2, a dose of 0.5 mg/kg and
5 μg/mouse dissolved in a volume of 200 μL saline was applied,
respectively. Twenty-four h after infection, some animals
showed signs of diarrhea and stopped eating and drinking,
which resulted in a higher weight loss compared to the control
group (Figure 2A). All infected mice developed to a similar
extent signiﬁcantly elevated leukocyte counts in the peritoneal
lavage (p < 0.01) as well as increased MPO activity (p < 0.05)
in the lungs as a result of neutrophilic inﬂux while white blood
counts in blood did not change signiﬁcantly compared to the
controls. In addition, animals showed enhanced serum levels of
diﬀerent cytokines (IL-6, IL-10, G-CSF, and TNFa) and
chemokines (KC, MCP-1, MIP-1a, RANTES) demonstrating
that an intense systemic inﬂammatory response has developed
(Figure 2B). Extremely high cytokine and chemokine
concentrations were found for S. aureus and E. coli infections
and for mice having been treated with LPS. Taken together,
these data show that in all cases a systemic infection was
obtained. Although the responses did vary in magnitude with S.
aureus and E. coli having the highest responses, the responses
for all bacteria, LPS and MALP2 were elevated in a similar
direction.
Metabolic Similarities and Diﬀerences between E. coli, P.
aeruginosa, S. aureus, and S. pneumoniae infections
To determine whether the metabolomic proﬁles of diﬀerent
infections were suﬃciently unique to facilitate the identiﬁcation
of bacteria speciﬁc biomarkers, supervised multivariate
statistical modeling was applied to a set of 43 identiﬁed
serum metabolites obtained from S. aureus, S. pneumoniae, E.
coli and P. aeruginosa infected mice. Metabolites that were
identiﬁed included several intermediates of the tricarboxylic
acid (TCA) cycle, glycolysis, as well as fermentation and lipid
precursor metabolites. In addition, ketone bodies, amino acids,
as well as carboxylic acids which were caused by direct cellular
events were detected. Some metabolites such as taurine are
related to the innate immune system and released by the
polymorphonuclear cells, while others derive from bacteria in
the gut and at the site of infection. A full list of metabolites and
Figure 2. Physiological and immunological conditions in response to bacterial infections and to LPS and MALP2 administration, 24 h post-infection.
C57BL/6 wild-type mice were infected intraperitoneally with 1 mL of S. aureus (S.a.), S. pneumoniae (S.p.), E. coli (E.c.), and P. aeruginosa (P.a.)
suspensions. Saline, LPS, and MALP2 were also ip-injected. (A) Weight loss, MPO activity from lung tissue and leukocyte counts from both blood
and peritoneal lavage. Signiﬁcance of paired t tests on diﬀerences in physiological parameters between controls and infected mice (1) p < 0.01, (2) p
< 0.002, (3) p < 0.05. White blood cell counts did not diﬀer signiﬁcantly between the control group and infected mice. (B) Levels of cytokines and
chemokines in mouse serum.
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Supporting Information.
Using PLS-DA, a clear separation between the four bacterial
strains was obtained (Figure 3A). Three components of the
PLS-DA analysis encapsulated 71% of the interclass variation
(R2) with a corresponding cross-validation accuracy of 56%
(Q2). Coeﬃcients of metabolites for diﬀerent bacterial
infections showed that each infection was correlated to speciﬁc
changes in certain metabolic intermediates (Table 2A−D,
Supporting Information). Mice infected with S. aureus showed
extremely enhanced serum levels of metabolites related to fatty
acid oxidation such as acetone, 3-hydroxybutyrate, and 2-
hydroxybutyrate as well as isobutyrate and creatine. In contrast,
in S. pneumoniae infections these metabolites were identiﬁed as
negative contributors, and TCA cycle intermediates (2-
oxoglutarate, citrate, and fumarate) as well as glucose and
pyruvate showed the highest serum levels compared to all
infections investigated. Hippurate, a carboxylic acid and
endogenous conjugate which is not further metabolized but
actively secreted by tubular cells and excreted in urine,
36
became a metabolite of special interest as its serum
concentrations rose by almost 100% during the pneumococcal
infection. It is produced by condensation of benzoic acid and
glycine in the mitochondria of liver and kidney,
37,38 and its
synthesis is stimulated by metabolic acidosis. It belongs to the
group of uremic toxins, and its enhancement in urine is often
used as an indicator of intrahepatic tracer dilution to determine
the activity of speciﬁc human enzymes.
39,40 Therefore, unlike
the cytokines and chemokines which simply indicated
indiscriminate inﬂammation, metabolites highlighted striking
diﬀerences.
As for the Gram-negative bacterial strains, the distinction
between the metabolic proﬁles of E. coli and P. aeruginosa
infections was mainly based on changes in amino acid blood
levels, whereas varying concentration changes of energy
metabolites were observed.
Besides signiﬁcant distinction between diﬀerent bacterial
infections, similarities also became obvious in the 3D PLS-DA
scores plot (Figure 3B). The clustering of S. aureus and S.
pneumoniae infected mice showed similar metabolite changes in
the third principal component while similar values for the ﬁrst
and second principal component along the x2 − y2 axis, were
obtained for E. coli and P. aeruginosa infections. Using the
supervised OPLS-DA (orthogonal partial least-squares discrim-
inant analysis; two components, R2 = 0.81, Q2 = 0.59) analysis
(Figure 3C), serum samples of mice infected with Gram-
positive and Gram-negative bacteria clustered as two separate
groups. Five of 10 metabolites that were identiﬁed as signiﬁcant
positive contributors in the class of Gram-positive bacterial
infections (Table 2E, Supporting Information) were glycolysis
and TCA cycle intermediates such as glucose, pyruvate, citrate,
fumarate, and 2-oxoglutarate. Amino acids, in contrast, were
found in higher levels in blood of mice infected with Gram-
negative bacteria.
Taken together, these results demonstrate that diﬀerent
bacterial infections give rise to individual metabolomic proﬁles
with overlapping similarities in metabolite classes according to
their gram nature.
Correlation between Bacteria Speciﬁc Metabolites in Vivo
and the Intra- and Extracellular Bacterial Metabolomes
To investigate whether some of the metabolites which were
identiﬁed as positive contributors for S. aureus, S. pneumoniae,
Figure 3. Scores plots representing 1H NMR spectral data from serum of C57BL/6 wild-type mice infected with four diﬀerent bacterial strains. Mice
were infected intraperitoneally with 1 mL of S. aureus (S.a.), S. pneumoniae (S.p.), E. coli (E.c.), and P. aeruginosa (P.a.) suspensions, and serum was
analyzed 24 h post administration. (A) 2D and (B) 3D PLS-DA scores plots (based on 43 metabolites) showing diﬀerentiation between the four
bacterially infected mouse models (three components; R2 = 0.71, Q2 = 0.56). The 3D plot represents similarities along the third principle
component for E. coli and P. aeruginosa infected groups and along the x2−y2 axis for S. aureus and S. pneumoniae infections. (C) OPLS-DA scores plot
separating the samples of Gram-positive (S. aureus, S. pneumoniae) and Gram-negative (E. coli, P. aeruginosa) infections (two components; R2 = 0.81,
Q2 = 0.59).
Journal of Proteome Research Article
dx.doi.org/10.1021/pr201274r | J. Proteome Res. 2012, 11, 3231−3245 3236E. coli, and P. aeruginosa infections in vivo were derived directly
from bacterial metabolism, we conducted in vivo experiments
with bacterial cell cultures. By metabolic footprinting
(extracellular bacterial metabolites released into the culture
medium) and ﬁngerprinting (intracellular metabolites, ex-
tracted by organic solvents) we deﬁned the pattern of extra-
and intracellular bacterial metabolites, respectively. In our
experiments, bacteria were cultured to an OD600 of 0.6 in
either LB (S. aureus, P. aeruginosa, E. coli) or BHI (S.
pneumoniae) medium and were separated subsequently using
the ﬁltration method (0.2 μm). Intracellular metabolites were
extracted by cold methanol, and NMR data were collected from
both extracts (ﬁngerprints) and culture media (footprints). In
these spectra we identiﬁed and quantiﬁed 39 metabolites
including amino acids, alcohols, and organic acids. Since
cultivation of the diﬀerent bacterial strains required diﬀerent
culture media, we compared the metabolic footprint of each
pathogen directly with that of the corresponding culture
medium using OPLS-DA. In S. pneumoniae, S. aureus, and E. coli
cultures, metabolite levels linked to pathways of energy supply
increased signiﬁcantly during cell growth, while most of the
amino acid concentrations decreased and were taken up by the
bacteria to be used for protein, DNA/RNA, and cell wall
synthesis.
For P. aeruginosa, in contrast, metabolomic footprints
displayed increased concentrations for a variety of diﬀerent
amino acids, while positive contributors derived from anaerobic
or aerobic energy metabolism were not discovered. A
comparison of the metabolic proﬁles with those from serum
of P. aeruginosa infected mice showed similarities for a large
number of metabolites (Figure 4A), indicating that P.
aeruginosa secretes speciﬁc metabolites which contribute
directly to the serum metabolome. In subsequent experiments,
P. aeruginosa suspensions were injected at diﬀerent concen-
trations (7 × 102,8× 104,1× 106,5× 106 CFU/mL) to
investigate the eﬀects of increasing bacterial load and disease
stages in the mouse model. Even though MPO and leukocyte
counts in the peritoneal lavage increased signiﬁcantly beginning
with a bacterial concentration of 1 × 106 CFU/mL, no
signiﬁcant changes in WBC or severe disease symptoms as
Figure 4. Bacterial exometabolome and metabolic host response to P. aeruginosa infected C57BL/6 wild-type mice 24 h post-infection. Some of the
elevated serum metabolites of P. aeruginosa infected mice were identiﬁed as part of the bacterial exometabolome. (A) Coeﬃcient plot generated from
OPLS-DA analysis of the samples from the P. aeruginosa mouse model and control animals representing the relative contribution that each
metabolite makes to the distinction between the two classes (two components; R2 = 1.00, Q2 = 0.99). Highlighted metabolites (red circles) were
elevated both in serum samples of infected mice and in the footprints of P. aeruginosa cultures grown in LB medium. Tryptophan, lysine, threonine,
valine, and phenylalanine were signiﬁcantly elevated both in vivo and in the bacterial culture media (p < 0.05). (B) Metabolite levels of tryptophan,
lysine, threonine, valine, and phenylalanine found in serum of mice infected with P. aeruginosa concentrations of 7 × 102,8× 104,1× 106, and 5 ×
106 CFU/mL. Bar charts showing (C) metabolite levels of taurine, ethanol, and creatine and (D) blood leukocyte counts from serum of P. aeruginosa
infected mice as a function of diﬀerent bacterial concentrations.
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were induced for the ﬁrst three bacterial concentrations.
However, serum levels of the ﬁve signiﬁcantly elevated
metabolites tryptophan, lysine, threonine, valine, and phenyl-
alanine continuously increased in serum with higher number of
bacteria. This indicates that these metabolites may be released
by the bacteria as bacterial footprints into the bodily ﬂuids
(Figure 4B). On the other hand, a more profound host
response was observed when a P. aeruginosa suspension with a
concentration of 5 × 106 CFU/mL was applied. At 24 h post
administration, these mice developed signs of severe sickness
(decreased WBC, increased neutrophil-lymphocyte ratio) and
also experienced decreased serum amino acid levels (Figure 4B)
as well as elevated serum concentrations of ethanol, taurine,
and creatine (Figure 4C) and a mortality rate of 50%.
For E. coli, S. aureus, and S. pneumoniae infected mice the
similarities between the in vivo experiments and the bacterial
culture footprint experiments were less distinctive. For E. coli
and S. aureus only ethanol and acetone were found as secreted
metabolites, while for S. pneumoniae, none of the increased
serum and footprint compounds overlapped.
Fingerprint analysis by PLS-DA (three components, R2 =
0.98, Q2 = 0.98) showed clear separation between all four
bacterial strains with diﬀerences in amino acid levels, energy
metabolites as well as organic acids. However the metabolites
found intracellularly in the bacterial cultures did not correlate
with any metabolites found in the serum of the infected mice.
Characterization of the Eﬀects of Virulence Factors in the
Host
In order to distinguish between bacteria and host responses we
injected mice with LPS or MALP2 to activate diﬀerent TLRs.
The advantage of using LPS over intact bacteria is that it should
elicit a host response for a Gram-negative organism but does
not contribute bacterial metabolites. Likewise, MALP2
emulates a host response for Gram-positive bacteria. Separate
PLS-DA models were constructed comparing infected, non-
infected and either LPS or MALP2 treated mice. The
corresponding scores plots showed well separated clusters of
diﬀerently treated mice but also demonstrated similar trends for
groups exposed to similar cell constituents (Figure 5). Gram-
negative infected mice and animals having received LPS
clustered together and were clearly separated from controls
along the ﬁrst component. However the E. coli and P. aeruginosa
induced infections gave rise to an additional shift in the second
principal component, compared to LPS treatment. In multi-
variate statistical modeling, the ﬁrst component explains the
largest source of variance in the data set, while subsequent
components are orthogonal to each other and explain lower
levels of data variance. Clearly, the TLR-mediated response
provides the major source of variance in the case of Gram-
negative bacteria. Very similar results were obtained for the
comparison of the S. pneumoniae infected mice and those
treated with the synthetic TLR2 agonist MALP2. In contrast,
the S. aureus infected and MALP2 treated groups displayed
signiﬁcant diﬀerences along the ﬁrst component. Compared to
controls, S. aureus infected mice showed clear discrimination
both along the ﬁrst and second component while the MALP2
treated animals diﬀered from the controls only along the
second component. While activation by LPS is obviously the
most important virulence factor for E. coli and P. aeruginosa
infections, for S. aureus it appears that most of the metabolic
changes are not related to a MALP2-induced host response.
Correlation between Metabolite Proﬁles and Toll-Signaling
Pathways
The putative signaling receptors for LPS and MALP2 are TLR4
and TLR2, respectively. To identify speciﬁc metabolites which
increase in response to the activation of the TLR4 and TLR2
receptors, we studied knockout mice. We ﬁrst compared serum
Figure 5. Similarities between TLR2 and TLR4 agonists and Gram-positive and Gram-negative bacterial infections. PLS-DA scores plot of serum 1H
NMR data of (A) P. aeruginosa (three components, R2 = 0.92, Q2 = 0.81) or (C) E. coli (two components, R2 = 0.77, Q2 = 0.65) infected mice vs
LPS treated animals and controls and (B) S. pneumoniae (two components, R2 = 0.92, Q2 = 0.81) or (D) S. aureus (two components, R2 = 0.76, Q2
= 0.60) infected mice vs MALP2 treatment and controls.
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dx.doi.org/10.1021/pr201274r | J. Proteome Res. 2012, 11, 3231−3245 3238Figure 6. Physiological response and the metabolites and cytokines activated by the TLR4 receptor and associated signaling pathway. (A) + (B)
PLS-DA modeling of metabolite concentrations identiﬁed in serum of C57BL/6 wild-type (two components, R2 = 0.76, Q2 = 0.60) and in (C) +
(D) TLR4 deﬁcient mice (two components, R2 = 0.91, Q2 = 0.70) 24 h after LPS treatment and E. coli infection. (A) and (C) represent scores plots
from the PLS-DA analysis and (B) and (D) the corresponding loadings plots. Metabolites which were signiﬁcantly enhanced in response to both
LPS treatment and E. coli infection are highlighted in blue, those speciﬁc for LPS or E. coli are highlighted in green and red, respectively. In addition
Journal of Proteome Research Article
dx.doi.org/10.1021/pr201274r | J. Proteome Res. 2012, 11, 3231−3245 3239metabolite proﬁles of noninfected, E. coli infected and LPS
treated animals both in C57BL/6 wild-type (two components,
R2 = 0.76, Q2 = 0.60) and TLR4-deﬁcient mice (two
components, R2 = 0.91, Q2 = 0.70) using PLS-DA models
(Figure 6). The corresponding loading plots in Figure 6 B and
D give an overview of the metabolites causing the observed
clustering. As shown in the previous section, in the wild-type
mouse both E. coli infected and LPS treated animals showed
similar changes in their metabolite proﬁles compared to
controls, although they also diﬀered from each other along
the second principal component. In order to distinguish
between metabolites which increased in response to an E. coli
infection or to LPS treatment and those which were elevated in
both groups, we compared each group with control animals
separately via OPLS-DA. Ethanol, acetone, alanine, valine, and
threonine (highlighted in red) showed substantially higher
serum levels in E. coli infected mice than in controls, whereas
the serum concentrations of creatine, hippurate, histidine, 2-
hydroxybutyrate, taurine, and tryptophan (highlighted in green)
were signiﬁcantly elevated in the LPS group. Both disease
initiators gave rise to a strong immune response and severe
disease symptoms (Figure 6 E and F) and resulted in similar
serum levels of lysine, leucine, isoleucine, ornithine, and
phenylalanine in wild-type mice (highlighted in blue). In
contrast in TLR4-deﬁcient mice, cytokine responses and
disease parameters were completely attenuated in the LPS
group and strongly suppressed in infected mice identifying the
TLR4 signaling pathway as major host response for E. coli
infections. In the LPS group, normal serum concentrations
were obtained similar to controls. Indeed the PLS-DA scores
plot of the serum samples obtained from TLR4 deﬁcient mice
revealed only two clusters without any distinction between the
control and LPS group (Figure 6C). Encouragingly, wild-type
and TLR4 deﬁcient mice respond in a similar manner to E. coli
as evidenced by the fact that several of the induced metabolites
are similar. Corresponding experiments were performed for S.
aureus infected mice. The metabolite proﬁles in wild-type
(Figure 7 A and B) and TLR2-deﬁcient (Figure 7 C and D)
mice were compared with those of controls as well as with
MALP2 treated mice. In the loadings plot, we identiﬁed
metabolites in serum of wild-type mice which were speciﬁcally
elevated by the S. aureus infection (glycerol, creatine, acetone;
highlighted red), compounds which were strongly elevated in
response to MALP2 treatment (taurine, lactate, valine,
isoleucine; highlighted green), and those found in increased
concentration in both groups (lysine, isobutyrate; highlighted
blue).
Similar to the E.coli and LPS experiments, described above,
the class distinction between all three groups observed in wild-
type mice was eliminated in TLR2 knockout mice and only
metabolite proﬁles of mice with the S. aureus infection diﬀered
from those of the controls. Cytokine screening and blood cell
analysis (Figure 7 E and F) conﬁrmed that the TLR2-deﬁcient
mice had a reduced response to MALP2. However most of the
cytokine levels remained elevated in S. aureus infected TLR2
knockout mice, indicating that other immune pathways are
mainly activated.
Correlations between Metabolic, Physiological, And
Immunological Responses
To further investigate the covariation between metabolite levels
and host response, PLS regression analysis of all four bacterial
infections was performed using the physiological/immunolog-
ical characteristics as y variables and metabolite concentrations
as x variables (three components, R2 = 0.72, Q2 = 0.52).
Several statistically signiﬁcant correlations between physiolog-
ical and immunological parameters and corresponding
metabolite proﬁles could be derived (Figure 8). Besides well-
known positive correlations between neutrophils and taur-
ine
41,42 and weight loss and ketone bodies, correlations were
also found between some cytokines and serum metabolites. For
example, a positive correlation was found between IL6 and
serum concentrations of acetone, formate, creatine, and 2-
hydroxybutyrate. Similar positive relationships were identiﬁed
for TNFa, G-CSF, and KC, while most of the cytokines and
chemokines were negatively correlated with choline, glucose, as
well as the TCA cycle intermediates citrate and 2-oxoglutarate.
■ DISCUSSION
In this work, we used a simple intraperitoneal mouse model to
study bacterial infections. One of our main interests was the
comparison between the eﬀects of Gram-positive and Gram-
negative infections on the physiological, immunological, and
metabolite response of the host. We selected for the study
various bacterial strains of clinical signiﬁcance: the Gram-
positive strains S. aureus and S. pneumoniae and the Gram-
negative strains E. coli and P. aeruginosa. In previous studies, the
two Gram-positive bacterial strains S. pneumoniae and S. aureus
have been compared in a mouse model,
18 and furthermore,
diﬀerent pneumonia infections have been investigated in
patients.
19 To the best of our knowledge, ours is the ﬁrst
study to use a metabolomics approach to make a direct
comparison between the eﬀects of Gram-positive and Gram-
negative bacteria. In order to establish that all four pathogenic
bacteria induced a systemic infection with similar disease
progression, we measured lung CFUs as well as several
physiological and immunological responses. Because we were
also interested in comparing the metabolic response and the
cytokine response to infection, we used mouse serum as the
bioﬂuid of choice for our studies. In previous studies we have
shown that the metabolomics analysis of mouse serum by
quantitative proton NMR gives useful information about the
onset of various diseases.
12,43−46 To facilitate comparisons, all
mice were harvested at 24 h after infection and all parameters
were measured at this time point.
Our results indicate that all four bacterially infected host
mouse models (S. aureus, S. pneumoniae, P. aeruginosa, E. coli)
gave rise to a distinct pathological phenotype based on the
metabolite proﬁles, suggesting that diﬀerent cellular functions
may be impaired (Tables 1 and 2, Supporting Information).
The signiﬁcantly enhanced serum levels of metabolites that are
related to fatty acid oxidation (e.g., the ketone bodies acetone
and 3-hydroxybutyrate) as well as increases in 2-hydroxybuty-
rate, isobutyrate, and creatine, which were found in S. aureus
Figure 6. continued
to metabolic proﬁles the subsequent panels show (E) leukocyte counts in blood and peritoneal lavage, MPO activity, weight loss as well as (F)
cytokine and chemokine concentrations in the serum.
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dx.doi.org/10.1021/pr201274r | J. Proteome Res. 2012, 11, 3231−3245 3240Figure 7. Physiological response and the metabolites and cytokines activated by the TLR2 receptor and associated signaling pathway. (A) + (B)
PLS-DA modeling of metabolite concentrations identiﬁed in serum of C57BL/6 wild-type (two components, R2 = 0.77, Q2 = 0.65) and in (C) +
(D) TLR2 deﬁcient mice (two components, R2 = 99, Q2 = 97) 24 h after MALP2 treatment and S. aureus infection. (A) and (C) represent scores
plots from the PLS-DA analysis and (B) and (D) the corresponding loadings plots. Metabolites which were signiﬁcantly enhanced in response to
both MALP2 treatment and S. aureus infection are highlighted in blue, those speciﬁc for MALP2 or S. aureus are highlighted in green and red,
respectively. In addition to metabolic proﬁles, the subsequent panels show (E) leukocyte counts in blood and peritoneal lavage, MPO activity, weight
loss as well as (F) cytokine and chemokine concentrations in the serum.
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hepatic cellular functions.
In contrast, perturbations in host TCA cycle metabolites
were mainly observed in S. pneumoniae infected mice. TCA
cycle precursors and intermediates such as glucose, pyruvate, 2-
oxoglutarate, citrate, and fumarate, which usually decrease in
times of sickness, showed the highest serum levels in S.
pneumoniae infected mice compared to the other bacterial
infections investigated in this study. These metabolites were
identiﬁed as main positive contributors in the PLS-DA model
(Table 2, Supporting Information). The pyruvate concentration
was even higher than in control mice. Unexpectedly high levels
of 2-oxoglutarate and fumarate were also found in the urine of
pneumococcal pneumonia patients.
19 In contrast to S. aureus
acetone, 2-hydoxybutyrate and isobutyrate were decreased.
Overall, both Gram-positive S. aureus and S. pneumoniae
infections gave rise to increased energy metabolites causing
clear distinction from the Gram-negative bacterial infections in
the OPLS model. With a > 50 % negative culture in septic
patients, it seems imperative that an alternative approach to
diagnosis is needed. Moreover, the blood cultures currently
used take several days to complete, and a fast method would
also be advantageous. Perhaps metabolomics can become a
useful clinical tool to distinguish between Gram-positive and
Gram-negative infections to better inform the physician.
Although encouraging, further studies are necessary to verify
and extend these initial observations.
In mice infected with Gram-negative bacteria, we observed
that amino acid serum levels were strongly elevated and were
partly derived from the bacterial exometabolome, particularly in
the case of P. aeruginosa infections. The secreted metabolites
identiﬁed in our bacterial culture experiments (Figure 4A) were
consistent with previous reports in the literature.
47 However,
bacterial metabolism strongly depends on culture conditions,
and the lack of agreement for metabolites found in vivo and in
cultures of S. aureus, S. pneumonia, and E. coli may be caused by
the diﬀerent composition of blood and culture media or the
oxygenation status.
Our study also demonstrated that metabolomics is a useful
tool to investigate the eﬀects of potential virulence factors and
signaling pathways in vivo. Comparisons of the serum
metabolites from mice treated with the immune stimulators
LPS and MALP2 and Gram-negative and Gram-positive
bacterial infections showed signiﬁcant similarities (Figure 5).
For example, the metabolite proﬁles of serum from mice
infected with E. coli and of mice treated with LPS diﬀered only
in the metabolites such as valine, threonine, alanine, acetone,
and ethanol (Figure 6). Acetone and ethanol were identiﬁed as
bacterial metabolites involved in cellular energy metabolism,
while the amino acids seemed to be induced by other virulence
factors diﬀerent from LPS.
Investigation of E. coli infection and LPS induced host
responses in both wild-type and TLR4 deﬁcient mice clearly
identiﬁed LPS as the main virulence factor. TLR4 was veriﬁed
Figure 8. Covariation between metabolic, physiological, and cytokine responses. Correlation circle (biplot, three components, R2 = 0.72, Q2 = 0.52)
of the four bacterial infections (S. aureus, S. pneumoniae, E. coli, P. aeruginosa) in C57BL/6 wild-type mice, their metabolites (x-variables), as well as
their physiological and immunological parameters (y-variables).
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bacteria resulting in reduced metabolic as well as physiological
and immunological responses to LPS in TLR4 deﬁcient mice.
In E. coli infected knockout mice in contrast, physiological and
metabolic responses to the infection remained observable while
their immunological response was almost completely attenu-
ated. The same metabolites which were signiﬁcantly elevated in
wild-type mice were also increased in TLR4 deﬁcient animals.
This indicates a strong correlation between physiological and
metabolic responses to an infection which seem to be
independent from the activation of the host immune response
and in this case TLR4 speciﬁcally.
In concordance with the E. coli/LPS experiment, the
metabolic, physiological, and immunological responses to
MALP2 were attenuated in TLR2-deﬁcient mice. The same
metabolites were elevated both in wild-type and TLR2 deﬁcient
mice in response to S. aureus infections. However similarities
between S. aureus and MALP2 were less obvious than for E. coli
and LPS pointing out the complexity of an S. aureus infection
and its virulence factors. In fact, the systemic chemokine/
cytokine responses to S. aureus were hardly diminished in the
TLR2 knockout mice, indicating that other host defense
signaling pathways are also involved. For S. aureus, a plethora of
superantigens, which can induce a strong immune response
with activation of T cells at picomolar concentrations, are
described in the literature
48 and may explain the observed
diﬀerences. Complement activation also is an important S.
aureus activation system. Finally, S. aureus also kills host cells
inducing activation of the inﬂammasome and the related sterile
injury danger signal pathways.
Relationships between the diﬀerent bacterial infections, their
metabolic, as well as their immunological and physiological
responses were further investigated in the biplot shown in
Figure 8. These data highlight the statistical relationships
between the metabolic, cytokine, and physiological responses to
infections. However, it is not clear at this stage whether there is
a direct mechanistic relationship between the metabolic and the
cytokine responses. The observed negative correlation between
cytokines and chemokines and the intermediates of energy
metabolism such as glucose, citrate, and 2-oxoglutarate may
simply be caused by their decreasing concentrations in times of
sickness. Similar reasoning may also apply to the relationships
observed between increased ketone body, creatine and formate
serum levels and elevated general cytokines such as IL-6, TNF,
and G-CSF as has already been discussed for cytokine and
metabolic proﬁles seen in protozoan infections.
49 Interestingly,
correlations between cytokine proﬁles and in vivo magnetic
resonance imaging and spectroscopy data have also been
reported.
50
Other support for this notion comes from the correlation
found between IL-10, MIP-1a, and RANTES and the amino
acids asparagine, phenylalanine, and histidine which have been
identiﬁed as positive contributors to the model in E. coli
infected mice. However, especially for E. coli it should be noted
that cytokine and chemokine screening showed extremely high
IL-10, MIP-1a, and RANTES levels which may explain the
observed covariation.
■ CONCLUSION
Our results suggest that diﬀerent bacterial strains give rise to
unique NMR-based serum proﬁles and that it might be possible
to use this approach in the future to distinguish between Gram-
positive and Gram-negative infections in a clinical setting. For
some bacterial strains, as is the case for P. aeruginosa, it might
be possible to directly identify the infecting organism because
they secrete speciﬁc metabolites into the host metabolome
which can be identiﬁed. The use of diﬀerent knockout mice
combined with the administration of speciﬁc bacterial virulence
factors allowed us to dissect bacterial and host responses. Our
results illustrate that this is a powerful approach that could be
applied in future studies of host response to other diseases or
insults. Finally, our quantitative approach allowed us to make
comparisons between the metabolic and physiological and
immunological responses to an infection which may lead to a
better understanding of the mechanisms of pathogenesis and
immunoregulation.
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